Show pageOld revisionsBacklinksFold/unfold allBack to top This page is read only. You can view the source, but not change it. Ask your administrator if you think this is wrong. ======= RBM14 ======= == Gene Information == * **<color #00a2e8>Official Symbol</color>**: RBM14 * **<color #00a2e8>Official Name</color>**: RNA binding motif protein 14 * **<color #00a2e8>Aliases and Previous Symbols</color>**: N/A * **<color #00a2e8>Entrez ID</color>**: [[https://www.ncbi.nlm.nih.gov/gene/?term=10432|10432]] * **<color #00a2e8>UniProt</color>**: [[https://www.uniprot.org/uniprot/Q96PK6|Q96PK6]] * **<color #00a2e8>Interactions</color>**: [[https://thebiogrid.org/search.php?search=RBM14&organism=9606|BioGRID]] * **<color #00a2e8>PubMed articles</color>**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20RBM14|Open PubMed]] * **<color #00a2e8>OMIM</color>**: [[https://omim.org/entry/612409|Open OMIM]] == Function Summary == * **<color #00a2e8>Entrez Summary</color>**: This gene encodes a ribonucleoprotein that functions as a general nuclear coactivator, and an RNA splicing modulator. This protein contains two RNA recognition motifs (RRM) at the N-terminus, and multiple hexapeptide repeat domain at the C-terminus that interacts with thyroid hormone receptor-binding protein (TRBP), and is required for transcription activation. Alternatively spliced transcript variants encoding different isoforms (with opposing effects on transcription) have been described for this gene. [provided by RefSeq, Oct 2011]. * **<color #00a2e8>UniProt Summary</color>**: N/A <button type='primary' size='sm' modal='Pfam_Domains'>Pfam Domains</button> <button type='primary' size='sm' modal='GO_terms'>GO Terms</button> <modal id='Pfam_Domains' size='lg' title='Pfam Domains'> |RRM 1| </modal> <modal id='GO_terms' size='lg' title='GO Terms'> |glucocorticoid receptor signaling pathway| |negative regulation of centriole replication| |corticosteroid receptor signaling pathway| |negative regulation of centrosome duplication| |negative regulation of centrosome cycle| |intracellular estrogen receptor signaling pathway| |regulation of centriole replication| |centriole assembly| |mediator complex| |negative regulation of organelle assembly| |regulation of centrosome duplication| |histone deacetylation| |protein deacetylation| |SMAD protein signal transduction| |regulation of centrosome cycle| |protein deacylation| |macromolecule deacylation| |nuclear receptor transcription coactivator activity| |intracellular steroid hormone receptor signaling pathway| |protein binding, bridging| |transcription coregulator activity| |microtubule organizing center organization| |steroid hormone mediated signaling pathway| |negative regulation of cytoskeleton organization| |ribonucleoprotein complex| |intracellular receptor signaling pathway| |hormone-mediated signaling pathway| |cellular response to steroid hormone stimulus| |regulation of microtubule cytoskeleton organization| |transmembrane receptor protein serine/threonine kinase signaling pathway| |transcription factor complex| |DNA replication| |regulation of organelle assembly| |DNA recombination| |regulation of microtubule-based process| |activation of innate immune response| |negative regulation of cell cycle process| |response to steroid hormone| |positive regulation of innate immune response| |positive regulation of response to biotic stimulus| |histone modification| |negative regulation of organelle organization| |covalent chromatin modification| |nuclear speck| |regulation of innate immune response| |positive regulation of defense response| |microtubule cytoskeleton organization| |DNA repair| |positive regulation of multi-organism process| |cellular response to lipid| |regulation of response to biotic stimulus| |regulation of cytoskeleton organization| |cellular response to organic cyclic compound| |negative regulation of cell cycle| |positive regulation of response to external stimulus| |cellular response to hormone stimulus| |activation of immune response| |microtubule-based process| |chromatin organization| |negative regulation of cellular component organization| |enzyme linked receptor protein signaling pathway| |DNA metabolic process| |regulation of cell cycle process| |organelle assembly| |regulation of defense response| |innate immune response| |regulation of multi-organism process| |cellular response to DNA damage stimulus| |response to lipid| |nucleolus| |positive regulation of immune response| |response to hormone| |response to organic cyclic compound| |defense response to other organism| |regulation of cellular component biogenesis| |chromosome organization| |regulation of response to external stimulus| |cytoskeleton organization| |positive regulation of immune system process| |regulation of immune response| |regulation of cell cycle| |positive regulation of transcription by RNA polymerase II| |cellular response to endogenous stimulus| |regulation of organelle organization| |response to other organism| |response to external biotic stimulus| |response to biotic stimulus| |defense response| |RNA binding| |response to endogenous stimulus| |regulation of response to stress| |positive regulation of transcription, DNA-templated| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |regulation of immune system process| |cellular response to stress| |cellular macromolecule biosynthetic process| |positive regulation of RNA metabolic process| |macromolecule biosynthetic process| |immune response| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |positive regulation of biosynthetic process| </modal> \\ === CRISPR Data === <button type='primary' size='small' modal='Compound_Hit'>Compound Hit</button> <button type='primary' size='small' modal='Most_Correlated_Genes'>Most Correlated Genes in Chemogenomics</button> <button type='primary' size='small' modal='Essential_Avana'>Tissues where Essential in the Avana Dataset (DepMap 20Q1)</button> <modal id='Compound_Hit' size='lg' title='Compound Hit'> ^Screen^Score^ |[[:results:exp122|Golgicide-A 4μM R03 exp122]]|-2.83| |[[:results:exp162|BI-D1870 2μM R04 exp162]]|-2.65| |[[:results:exp198|Etoposide 0.1μM R05 exp198]]|-2.37| |[[:results:exp124|GSK343 3μM R03 exp124]]|-2.35| |[[:results:exp273|Cisplatin 0.35μM R06 exp273]]|-2.34| |[[:results:exp185|L-BMAA 500 to 750μM on day4 R04 exp185]]|-2.31| |[[:results:exp65|Mubritinib 0.2μM R02 exp65]]|-2.25| |[[:results:exp73|LJH685 5μM R02 exp73]]|-2.21| |[[:results:exp520|Rucaparib 6.5μM R08 exp520]]|-2.13| |[[:results:exp153|SGC2096 2.6μM R03 exp153]]|-2.13| |[[:results:exp505|ML-792 0.2μM R08 exp505]]|-2.08| |[[:results:exp294|Nutlin-3A 1.6μM R06 exp294]]|-2.05| |[[:results:exp289|Hydroxyurea 15μM R06 exp289]]|-2| |[[:results:exp191|Hypoxia 5%O2 R04 exp191]]|-1.99| |[[:results:exp107|UMK57 0.6μM R03 exp107]]|-1.95| |[[:results:exp439|QNZ 0.01μM R08 exp439]]|-1.93| |[[:results:exp454|Bafilomycin-A1 0.009μM R08 exp454]]|-1.9| |[[:results:exp169|BH1 1μM R04 exp169]]|-1.9| |[[:results:exp59|UMK57 1μM R01 exp59]]|-1.9| |[[:results:exp508|NN-Dimethylsphingosine 2.5μM R08 exp508]]|-1.89| |[[:results:exp23|Nocodazole 0.02μM R00 exp23]]|-1.86| |[[:results:exp245|UM0011500 5μM R05 exp245]]|-1.85| |[[:results:exp156|UNC2400 2μM R03 exp156]]|-1.85| |[[:results:exp230|Epigallocatechin gallate 20μM R05 exp230]]|-1.81| |[[:results:exp130|JQ1 0.01μM R03 exp130]]|-1.8| |[[:results:exp128|GSK591 2.6μM R03 exp128]]|-1.74| |[[:results:exp329|Hydroxyurea 100μM R07 exp329]]|-1.74| |[[:results:exp54|Taxol 0.002μM R01 exp54]]|-1.74| |[[:results:exp48|Mubritinib 0.2μM R01 exp48]]|-1.73| |[[:results:exp422|Wiskostatin 3μM R07 exp422]]|-1.71| |[[:results:exp182|IU1-47 25μM R04 exp182]]|-1.7| |[[:results:exp489|Hippuristanol 0.12μM R08 exp489 no dilution day6]]|1.84| |[[:results:exp349|Cytochalasin-B 5μM R07 exp349]]|1.9| |[[:results:exp488|Hippuristanol 0.12μM R08 exp488]]|2.02| |[[:results:exp414|Tozasertib 0.1μM R07 exp414]]|2.31| |[[:results:exp343|Centrinone 0.5μM R07 exp343]]|2.32| |[[:results:exp96|BI-2536 0.02μM R03 exp96]]|2.33| |[[:results:exp126|GSK461364A 0.1μM R03 exp126]]|2.42| |[[:results:exp17|DABN 20μM R00 exp17]]|2.44| |[[:results:exp7|Bortezomib 0.05μM R00 exp7]]|2.92| |[[:results:exp93|DABN racemic mixture R03 exp93]]|3.84| |[[:results:exp111|R-DABN 8μM R03 exp111]]|3.87| |[[:results:exp244|SB743921 0.001μM R05 exp244]]|4.56| |[[:results:exp98|BI-6727 0.04μM R03 exp98]]|4.98| |[[:results:exp64|Nocodazole 0.2μM R02 exp64]]|5.42| |[[:results:exp94|Nocodazole 0.1μM R03 exp94]]|5.54| |[[:results:exp256|HMS-I1 10μM R06 exp256]]|6.07| |[[:results:exp33|Rotenone 2μM R00 exp33]]|6.36| |[[:results:exp208|Vinblastine 0.015μM R05 exp208]]|6.54| |[[:results:exp24|Nocodazole 0.2μM R00 exp24]]|6.58| </modal> <modal id='Most_Correlated_Genes' size='lg' title='Most Correlated Genes in Chemogenomics'> ^Gene^Correlation^ |[[:human genes:m:mad2l1|MAD2L1]]|0.816| |[[:human genes:m:mad1l1|MAD1L1]]|0.802| |[[:human genes:b:bub3|BUB3]]|0.763| |[[:human genes:k:kntc1|KNTC1]]|0.746| |[[:human genes:b:bub1b|BUB1B]]|0.72| |[[:human genes:z:zw10|ZW10]]|0.72| |[[:human genes:t:trip13|TRIP13]]|0.684| |[[:human genes:m:mad2l1bp|MAD2L1BP]]|0.655| |[[:human genes:z:zwilch|ZWILCH]]|0.648| |[[:human genes:f:fnta|FNTA]]|0.574| |[[:human genes:p:pelo|PELO]]|0.532| |[[:human genes:m:mars|MARS]]|0.506| |[[:human genes:m:med16|MED16]]|0.499| |[[:human genes:d:ddx20|DDX20]]|0.496| |[[:human genes:r:rtcb|RTCB]]|0.494| |[[:human genes:d:dpagt1|DPAGT1]]|0.493| |[[:human genes:t:tbca|TBCA]]|0.492| |[[:human genes:g:gnb1l|GNB1L]]|0.49| |[[:human genes:c:cdc20|CDC20]]|0.479| |[[:human genes:f:fntb|FNTB]]|0.471| |[[:human genes:a:alg1|ALG1]]|0.465| |[[:human genes:p:pam16|PAM16]]|0.464| |[[:human genes:t:trmt5|TRMT5]]|0.463| |[[:human genes:s:srp72|SRP72]]|0.459| |[[:human genes:u:uap1|UAP1]]|0.456| |[[:human genes:r:rnmt|RNMT]]|0.456| |[[:human genes:e:eprs|EPRS]]|0.448| |[[:human genes:n:nsmce1|NSMCE1]]|0.448| |[[:human genes:t:tti2|TTI2]]|0.446| |[[:human genes:d:dbr1|DBR1]]|0.446| |[[:human genes:d:dctn6|DCTN6]]|0.446| |[[:human genes:p:polr3b|POLR3B]]|0.444| |[[:human genes:p:polr3h|POLR3H]]|0.443| |[[:human genes:p:pmm2|PMM2]]|0.44| |[[:human genes:t:thg1l|THG1L]]|0.44| |[[:human genes:p:ppp4c|PPP4C]]|0.433| |[[:human genes:g:gtf3c2|GTF3C2]]|0.433| |[[:human genes:g:gtf3c4|GTF3C4]]|0.427| |[[:human genes:a:aars|AARS]]|0.426| |[[:human genes:d:dhps|DHPS]]|0.425| |[[:human genes:g:gfpt1|GFPT1]]|0.423| |[[:human genes:o:osgep|OSGEP]]|0.418| |[[:human genes:a:alg14|ALG14]]|0.418| |[[:human genes:r:rad1|RAD1]]|0.418| |[[:human genes:s:spcs2|SPCS2]]|0.418| |[[:human genes:t:tti1|TTI1]]|0.417| |[[:human genes:g:gemin5|GEMIN5]]|0.416| |[[:human genes:c:cdipt|CDIPT]]|0.415| |[[:human genes:r:rabggtb|RABGGTB]]|0.412| |[[:human genes:h:hbs1l|HBS1L]]|0.412| |[[:human genes:v:vmp1|VMP1]]|0.41| |[[:human genes:h:hars|HARS]]|0.408| |[[:human genes:t:tsen54|TSEN54]]|0.407| |[[:human genes:e:eif4e|EIF4E]]|0.4| </modal> <modal id='Essential_Avana' size='lg' title='Tissues where Essential in the Avana Dataset (DepMap 20Q1)'> Global Fraction of Cell Lines Where Essential: 607/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|1/1| |bile duct|24/28| |blood|26/28| |bone|22/25| |breast|27/33| |central nervous system|49/56| |cervix|4/4| |colorectal|15/17| |esophagus|9/13| |fibroblast|1/1| |gastric|13/15| |kidney|20/21| |liver|15/20| |lung|59/75| |lymphocyte|12/14| |ovary|21/26| |pancreas|21/24| |peripheral nervous system|12/16| |plasma cell|14/15| |prostate|1/1| |skin|17/24| |soft tissue|5/7| |thyroid|1/2| |upper aerodigestive|19/22| |urinary tract|25/29| |uterus|5/5| </modal> == Essentiality in NALM6 == * **<color #00a2e8>Essentiality Rank</color>**: 288 * **<color #00a2e8>Expression level (log2 read counts)</color>**: 6.76 <button type='primary' size='small' modal='Dist_expr'>Expression Distribution</button> <modal id='Dist_expr' size='lg' title='RBM14 Expression in NALM6 Cells: 6.76'> {{:chemogenomics:nalm6 dist.png?nolink |}} </modal> Last modified: 2025/12/10 20:19by 127.0.0.1